Stocks
FibroGen (FGEN) ROE US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| ROE, % | ? | -138.7% | 1 369% | 139.2% | 21.1% | 4 099% | -1 761% | |
| Changes by years, y/y, % | -94pp | +1 508pp | -1 230pp | -118pp | +4 078pp | |||
FibroGen. ROE, %
FibroGen. ROE, changes, pp
FibroGen (FGEN) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | 0.93% | -1 266% | 4 099% | -1 761% | -2 249% | -1 761% | |
| Changes by years, y/y, % | -72pp | -1 316pp | +4 078pp | -1 766pp | -2 250pp | |||
| Changes by quarters, q/q, % | -4pp | -1 267pp | +5 366pp | -5 861pp | -488pp | |||
